Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
DB Securities Co., Ltd. (016610.KS)
Seoul, KR
Headquartered in Seoul, South Korea, DB Financial Investment Co., Ltd. has been delivering a broad spectrum of financial products and services since its inception in 1982. The company's diverse offerings span asset management, various insurance products (including life insurance), savings bank facilities, and brokerage services. It also specializes in bond dealing, investment banking (IB), investment trusts, and extends its reach into international business operations. Furthermore, the firm manages mid to long-term investments, conducts trading in stocks and derivatives, facilitates asset transactions, and provides crucial tax, legal, and risk management advice to its clients.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -3.00% | -19.01% | -8.16% | -28.11% | +17.30% | +15.37% | +100.16% | +203.86% | +73.45% | +240.81% | +155.93% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Financial - Capital Markets: +19.7%+23.6% ★ Q1'26: -141.8% (vs Q1'25)
-
EPS growth Financial - Capital Markets: +35.3%+64.6% ★ Q1'26: +46.9% (vs Q1'25)
-
FCF margin FCF growth · Financial - Capital Markets: +29.5%+251.6% Q1'26: -917.9% (vs Q1'25)
-
EBIT margin Financial - Capital Markets: +33.5%+35.7% ★ Q1'26: -120.0% (vs Q1'25)
-
ROIC Financial - Capital Markets: +4.0%+4.7% ★ Q1'26: +5.0% (vs Q1'25)
-
Share dilution Financial - Capital Markets: +0.0%+4.4% Q1'26: -0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Financial - Capital Markets: -0.30×21.25× Q1'26: 17.31× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-14 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-12 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-08 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-22 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-21 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-20 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-17 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
| 2026-04-16 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.04% | 17.9K | 0.54% |
| 2 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.04% | 658.3K | 0.58% |
| 3 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.02% | 19.4K | 0.42% |
| 4 | Kodex KOSPI 226490.KS | 0.01% | 98.9K | 0.15% |
| 5 | Avantis Emerging Markets Value ETF AVES | 0.01% | 182.9K | 0.36% |
| 6 | Avantis Emerging Markets ex-China Equity ETF AVXC | 0.01% | 23.0K | 0.33% |
| 7 | Dimensional - Emerging Markets Value ETF DFEV | 0.00% | 87.0K | 0.46% |
| 8 | Avantis Emerging Markets Equity UCITS ETF USD Acc AVEM.L | 0.00% | 8.8K | 0.35% |
| 9 | Dimensional Emerging Markets Sustainability Core 1 ETF DFSE | 0.00% | 14.6K | 0.44% |
| 10 | Dimensional - Emerging Markets Core Equity 2 ETF DFEM | 0.00% | 204.1K | 0.39% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Bong Seok Kwak | Chief Executive Officer | 2B | — |
| Hyung-Min Seo | Senior Vice President | 933M | male |
| In Cheol Han | MD of Trading & Head of Operations | — | — |
| Jong Cheon Choi | Executive Director & Compliance Officer | — | — |
| Kiho Park | Vice President, Head of Management Support Office, Chief Financial Officer & Director | — | male |
| Kwang-Yol Lee | Senior Executive Vice President | — | — |
| SeYeon Hwang | MD & Head of Corporate Finance Division | — | — |
| Baek Ripening | President & Strategic Planning Manager | — | — |
| Sok-Yoon Kang | MD, Executive Vice President & Head of Audit Office | — | — |
| Geum-Seok Kim | Executive Vice President, MD & Head of Equity Division | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 016610.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
